کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2100871 1083083 2015 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Targeting the ubiquitin pathway for cancer treatment
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
Targeting the ubiquitin pathway for cancer treatment
چکیده انگلیسی


• Ubiquitin ligases play a crucial role in the development and progression of cancer.
• Ubiquitin pathway components could be effective drug targets for cancer therapy.
• Bioactive compounds targeting ubiquitin pathway for cancer treatment are summarized.

Proteasome-mediated degradation is a common mechanism by which cells renew their intracellular proteins and maintain protein homeostasis. In this process, the E3 ubiquitin ligases are responsible for targeting specific substrates (proteins) for ubiquitin-mediated degradation. However, in cancer cells, the stability and the balance between oncoproteins and tumor suppressor proteins are disturbed in part due to deregulated proteasome-mediated degradation. This ultimately leads to either stabilization of oncoprotein(s) or increased degradation of tumor suppressor(s), contributing to tumorigenesis and cancer progression. Therefore, E3 ubiquitin ligases including the SCF types of ubiquitin ligases have recently evolved as promising therapeutic targets for the development of novel anti-cancer drugs. In this review, we highlighted the critical components along the ubiquitin pathway including E1, E2, various E3 enzymes and DUBs that could serve as potential drug targets and also described the available bioactive compounds that target the ubiquitin pathway to control various cancers.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer - Volume 1855, Issue 1, January 2015, Pages 50–60
نویسندگان
, , , , , , ,